Thymoma: current medical and surgical management.
Thymoma is a rare neoplasm usually with an indolent growth pattern; however, local invasion and/or dissemination may occur. Surgery has been the standard of care for early stage disease with good to excellent cure rates anticipated. This neoplasm has been found to be relatively sensitive to cisplatinum-based chemotherapy as compared with most other epithelial tumors. Aggressive multimodality therapy therefore can result in long-term disease-free survival for patients presenting with locally advanced or even disseminated disease. This chapter outlines the current medical and surgical treatment options for thymoma.
Kesler
Kenneth A
KA
Thoracic Division, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Wright
Cameron D
CD
Loehrer
Patrick J
PJ
D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D015996:Survival Rate / Q000639:trends; D013934:Thymectomy / Q000706:statistics & numerical data / Q000639:trends; D013945:Thymoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery*; D013950:Thymus Gland / Q000000981:diagnostic imaging* / Q000601:surgery*; D013953:Thymus Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery*; D014057:Tomography, X-Ray Computed
D002945:Cisplatin